---
title: "Viking Therapeutics Announces Two Poster Presentations at European Congress on Obesity (ECO) 2026 | VKTX Stock News"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/285192819.md"
description: "Viking Therapeutics Announces Two Poster Presentations at European Congress on Obesity (ECO) 2026 | VKTX Stock News"
datetime: "2026-05-05T03:05:32.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/285192819.md)
  - [en](https://longbridge.com/en/news/285192819.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/285192819.md)
---

# Viking Therapeutics Announces Two Poster Presentations at European Congress on Obesity (ECO) 2026 | VKTX Stock News

Viking Therapeutics Announces Two Poster Presentations at European Congress on Obesity (ECO) 2026 | VKTX Stock News

### Related Stocks

- [VKTX.US](https://longbridge.com/en/quote/VKTX.US.md)
- [FBT.US](https://longbridge.com/en/quote/FBT.US.md)
- [XBI.US](https://longbridge.com/en/quote/XBI.US.md)
- [BBH.US](https://longbridge.com/en/quote/BBH.US.md)
- [SBIO.US](https://longbridge.com/en/quote/SBIO.US.md)
- [BIB.US](https://longbridge.com/en/quote/BIB.US.md)
- [LABU.US](https://longbridge.com/en/quote/LABU.US.md)
- [IBB.US](https://longbridge.com/en/quote/IBB.US.md)

## Related News & Research

- [Full Transcript: Cellectar Biosciences Q1 2026 Earnings Call](https://longbridge.com/en/news/286422585.md)
- [Eton Pharmaceuticals Q1 product sales rise driven by portfolio expansion](https://longbridge.com/en/news/286461579.md)
- [Co-Diagnostics Advances Ebola Preparedness With New Bundibugyo Virus Assay Strategy; Stock Up](https://longbridge.com/en/news/286956797.md)
- [08:00 ETAvance Clinical Receives Frost & Sullivan's 2026 Global Company of the Year Recognition for Excellence in Biotech CRO Leadership](https://longbridge.com/en/news/286094661.md)
- [Genprex data shows gene therapy reverses hyperglycemia in T2D mice at ASGCT](https://longbridge.com/en/news/286414681.md)